- https:/
- /
- pyrexar.com/ 175 pages
- Pyrexar Medical- Hyperthermia products treat cancer
- Great Clinical Results for Pyrexar HT Hyperthermia
- Blogging about Hyperthermia
- About Pyrexar Medical
- Soft Tissue Sarcoma Patients Living Longer with Hyperthermia
- Pyrexar Medical Inc. - Privacy Policy
- IFU Login
- BSD-2000 Deep Phased Array Commercial Product Comparative Table
- RF Isolation Cage for the BSD-2000
- Pyrexar Medical - Breast Cancer
- Pyrexar Medical - Cervical Cancer
- Pyrexar Medical - Esophageal Cancer
- Pyrexar Medical - Head and Neck Cancer
- Pyrexar Medical - Rectal Cancer
- Pyrexar Medical - Sarcoma Cancer
- Pyrexar Medical - Pediatric Cancer
- Improve Anal Treatment Results with Hyperthermia
- FAQ - General
- FAQ - 500 Superficial
- FAQ - 2000
- FAQ - 2000 3D/MR
- Training Program
- Blogging about Hyperthermia
- Blogging about Hyperthermia
- Blogging about Hyperthermia
- Blogging about Hyperthermia
- Blogging about Hyperthermia
- Blogging about Hyperthermia
- Blogging about Hyperthermia
- Blogging about Hyperthermia
- Blogging about Hyperthermia
- Frequently Asked Questions
- ASMED Medical Devices
- Free Issue of the International Journal of Hyperthermia
- Pyrexar Expands into 13 Countries
- IFU Login
- IFU Login
- Pyrexar Medical- Hyperthermia products treat cancer
- Great Clinical Results for Pyrexar HT Hyperthermia
- About Pyrexar Medical
- Blog
- BSD-2000 3D More Info
- Univ. Maryland Hyperthermia Presentation
- Thermal-Release Drug Targeting Moves Forward
- Thermal Oncology Team Training - Hanoi
- New hyperthermia installation in Rome
- Protons, Protons, Protons
- U of M Proton Center Celebrates Milestone
- Can Hyperthermia Improve Particle Beam Therapy?
- Busy Week For Hyperthermia
- Pyrexar Exhibits at ABS Annual Meeting
- ESHO 33 Approaching
- Hyperthermia Experts Gather in Milan
- Hyperthermia + Proton Therapy, Now in US
- A Great Four Years
- St. John / Ascension adds Hyperthermia to Treat Cancer
- STM Focuses on Clinical Hyperthermia
- Siteman Cancer Center chooses Pyrexar
- Bringing Thought Leaders Together
- 2019 Hyperthermia Conference Events
- The Impact of Personal Stories
- ABC News - Why people don't know about life saving cancer treatment: hyperthermia
- ABC News - Tour of Pyrexar and the people behind hyperthermia machines
- ABC News - Hyperthermia treatment targets cancer tumor and boosts own body's immune system
- ABC News - Hyperthermia in the fast lane helping heat and kill cancer tumors
- ABC News - What is the anti-cancer treatment hyperthermia?
- TASTRO a Success in Taiwan
- ASTRO 2018 in Review
- New Study Supporting Focus and Steering
- New Website Update
- Wan Fang Opens their Doors to Share Hyperthermia Experience
- Visit Pyrexar at ASTRO 2018 San Antonio, Booth 1942
- Kamol Sukosol Electric Co (KEC) to represent Pyrexar in Thailand
- Pyrexar to Deliver Hyperthermia Products to Viet Nam
- A Great Program at STM 2018
- Bringing Hyperthermia to Việt Nam
- Bringing Hyperthermia to Kuwait
- ESHO 2018 Meeting Update from Sennewald Medizintechnik
- STM and ESHO Event Reminder
- Pyrexar Entering the Middle East Marketplace
- Where Have You Been? Trip Report : India
- Advanced Medical Transfers Japan Distribution Rights to Fingall-Link
- PTHO Congress was a Great Success
- New Image Guided Hyperthermia System Now in Service
- Is there a Future for Capacitive Hyperthermia?
- South Korea, ASTRO, JCA and a Correction
- Taiwan Partners and Water
- International Scientific Conference of the Polish Society for Hyperthermic Oncology
- Kirloskar Group Brings Hyperthermia Cancer Treatment to India
- Recent visit to China
- Saudi Cancer Foundation brings Hyperthermia Awareness to KSA
- Hyperthermia Takes Center Stage in South Korea
- STM 2017 Highlights
- ABC News Report on Hyperthermia - Part 5
- ABC News Report on Hyperthermia - Part 1
- ABC News Report on Hyperthermia - Part 2
- ABC News Report on Hyperthermia - Part 3
- ABC News Report on Hyperthermia - Part 4
- Study Shows Capacitve Heating the Poor Choice
- Join Us at the 34th Annual STM
- RSNA Trade Show Booth Mock-up
- World's Largest Hospital Supporting Hyperthermia
- Robots Invade ASTRO 2016
- ASTRO, Hyperthermia and RVUs
- ASTRO 2016 Setup Day
- HT+RT Beats CT+RT in Advanced Cervical Cancer
- Visit Pyrexar at RSNA 2016 Chicago, Booth 3276
- Where is the Evidence that Hyperthermia Works?
- Last Week at ASCO 2016
- Update: Pyrexar Day Speaker Schedule
- Pyrexar Celebrates its First Year
- CE•lebration at Pyrexar
- Pyrexar preparing to bring Hyperthermia Cancer Therapy to Cuba
- Today’s Big Deal is a Big Deal
- Treating patients with Hyperthermia in New Taipei City
- Magna Medic Making a Difference in Spain
- City of Dubai, like no other
- Hyperthermia Back in the National News
- RSNA in Review: Big Results for Pyrexar
- Pyrexar Heading to the RSNA
- Pyrexar presents at the Workshop on Hadron Therapy in Chiapas
- ASTRO 2015 was a big WOW
- Drones vs. Cranes, the future of product delivery
- Put Another Star on the Map
- Pyrexar Moves into its New Home
- Have you seen the Stapler?
- Deep Regional Hyperthermia Arrives in South Korea
- First Scratch Build Completed
- My Father Died Today
- Nanotechnology to Treat Cancer is Here
- Dr. Jan Vrba takes home this year's ESHO-Pyrexar Award
- Hyperthermia finds hopeful results for Pancreatic Cancer at CTCA
- Top Researchers Review Hyperthermia Evidence
- All Over the Map
- Hyperthermia shrinks tumors at Tacoma Valley R.O.C.
- China’s Fight Against Cancer gets a Boost from Hyperthermia
- How Superficial Hyperthermia Works
- How Deep Regional Hyperthermia Works
- STM - Society of Thermal Medicine
- Putting the Heat on Tumors
- Science of Hyperthermia
- BSD-2000 Clinical Studies Table
- Blog
- Blog
- Blog
- Blog
- Blog
- Blog
- Welcome to Pyrexar Medical
- ESHO - European Society of Thermal Medicine
- Sales Agency
- Mitchell Nobile Internship
- ASTRO - American Society for Radiation Oncology
- Company Profile
- One More Year Campaign
- Welcome to Pyrexar Medical
- Pyrexar Medical- Hyperthermia products treat cancer
- RSNA - Radiological Society of North America
- About Us
- ICHO - International Congress of Hyperthermic Oncology, April 11-15
- HOTSTART Your Oncology Program
- Team
- Join Us at the ORR 2018 in Moscow
- RSNA - Radiological Society of North America
- Stop by our Booth at ASTRO 2017
- ASTRO - American Society for Radiation Oncology
- Join Us at the 31st Annual ESHO
- ESHO - European Society of Thermal Medicine
- Pyrexar Brochure Downloads
- BSD-500 Upgrade Promotion
- Job Poorly Done!
- Pyrexar Brochure Downloads
- Join Us at the 31st Annual ESHO
- Stop by our Booth at ASTRO 2017
- Join Us at the ORR 2018 in Moscow
- clinical-us/ 10 pages
- BSD-2000 Clinical Studies
- Randomized Clinical Hyperthermia Studies
- BSD-2000 Clinical Studies
- BSD-2000 Clinical Studies
- BSD-2000 Clinical Studies
- BSD-2000 Clinical Studies
- BSD-2000 Clinical Studies
- BSD-2000 Clinical Studies
- BSD-2000 Clinical Studies
- BSD-2000 Clinical Studies
- bsd-2000-clinical-studies/ 56 pages
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
- The Dutch Deep Hyperthermia Trial: results in cervical cancer
- Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial
- Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients
- Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
- Effectiveness of Regional Hyperthermia With Chemotherapy for High-Risk Retroperitoneal and Abdominal Soft-Tissue Sarcoma After Complete Surgical Resection
- Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
- Regional hyperthermia in patients with recurrent genitourinary cancer
- Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer
- External validation of a rectal cancer outcome prediction model with a cohort of patients treated with preoperative radiochemotherapy and deep regional hyperthermia
- Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer.
- Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma
- Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults
- Methods and potentials of magnetic resonance imaging for monitoring radiofrequency hyperthermia in a hybrid system
- A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy
- Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study
- Neoadjuvant chemotherapy followed by radiotherapy and concurrent hyperthermia in patients with advanced-stage cervical cancer: a retrospective study
- Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial
- Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96.
- Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum
- Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study
- Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS)
- Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia
- Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas
- Secondary external-beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate
- Phantom studies and preliminary clinical experience with the BSD 2000
- An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors
- Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update
- First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma
- Hyperthermia for the treatment of patients with malignant germ cell tumors: a phase I/II study in ten children and adolescents with recurrent or refractory tumors
- Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort
- Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia
- Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0
- Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations.
- Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky"
- Pre-operative radio-chemotherapy plus regional hyperthermia in the treatment of advanced rectal cancer: experience with radiation dose escalation
- Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer
- Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial
- The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy
- Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters
- A phase I/II study to evaluate radiation therapy and hyperthermia for deep-seated tumours: a report of RTOG 89-08
- Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: a preliminary report
- Re-irradiation and external hyperthermia in locally advanced, radiation recurrent, hormone refractory prostate cancer: a preliminary report
- Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect
- A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma
- Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study
- Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study
- Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study
- Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin
- Deep regional hyperthermia: comparison between the annular phased array and the sigma-60 applicator in the same patients
- A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix
- Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
- Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate.
- A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer.
- Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone
- Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study